Evolus (EOLS) Inventory Average (2019 - 2026)
Evolus (EOLS) posted Inventory Average of $25.9 million for Q1 2026, down 13.5% on a QoQ basis from $29.9 million in Q4 2025, and up 133.32% year-over-year from $11.1 million in Q1 2025.
Evolus (EOLS) Inventory Average (2019 - 2026) Analysis & Trends
Evolus' Inventory Average history runs 8 years deep, the most recent figure standing at $25.9 million for Q1 2026.
- Quarterly Inventory Average rose 133.32% year-over-year to $25.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.9 million (up 133.32% YoY) and the FY2025 annual result came in at $19.6 million, up 68.95% from the prior year.
- Inventory Average was $25.9 million for Q1 2026 at Evolus, down from $29.9 million in the prior quarter.
- Across five years, Inventory Average topped out at $29.9 million in Q4 2025 and bottomed at $2.7 million in Q1 2022.
- A 5-year average of $17.0 million and a median of $16.9 million in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average soared 686.13% — and 2024, when it slumped 46.66%.
- Evolus' Inventory Average stood at $20.2 million in 2022, then decreased by 29.18% to $14.3 million in 2023, then dropped by 5.5% to $13.5 million in 2024, then jumped by 121.2% to $29.9 million in 2025, then fell by 13.5% to $25.9 million in 2026.
- Business Quant data shows EOLS's Inventory Average at $25.9 million in Q1 2026, $29.9 million in Q4 2025, and $29.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 25.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.88 Mn |
| Dec 31, 2025 | 29.92 Mn |
| Sep 30, 2025 | 29.66 Mn |
| Jun 30, 2025 | 18.24 Mn |
| Mar 31, 2025 | 11.09 Mn |
| Dec 31, 2024 | 13.53 Mn |
| Sep 30, 2024 | 14.14 Mn |
| Jun 30, 2024 | 12.46 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Dec 31, 2023 | 14.31 Mn |
| Sep 30, 2023 | 18.74 Mn |
| Jun 30, 2023 | 21.64 Mn |
| Mar 31, 2023 | 21.14 Mn |
| Dec 31, 2022 | 20.21 Mn |
| Sep 30, 2022 | 16.93 Mn |
| Jun 30, 2022 | 7.95 Mn |
| Mar 31, 2022 | 2.69 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Sep 30, 2021 | 3.58 Mn |
| Jun 30, 2021 | 3.06 Mn |